ST8SIA6-AS1,在肝癌中的新型lncRNA明星
Cheng Qiu1, Haoran Fan2, Siyu Tao3
1Department of General Surgery, Pingxiang People's Hospital, Pingxiang, Jiangxi, China.
Frontiers in cell and developmental biology
|August 30, 2024
概括
ST8SIA6-AS1是一种致癌的长非编码RNA (lncRNA) 驱动肝癌. 它在肝细胞癌 (HCC) 的上调与预后不佳相关,有助于瘤生长,标记它作为潜在的诊断生物标志物.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 肝癌,特别是肝细胞癌 (HCC),仍然是一个重大的全球卫生挑战,死亡率高.
- 长非编码RNAs (lncRNAs) 越来越多地被认为对癌症的发展和进展起着关键作用.
- ST8SIA6-AS1已经成为一种新的lncRNA,涉及到各种癌症的发病,包括肝癌.
研究的目的:
- 在肝细胞癌 (HCC) 中审查ST8SIA6-AS1的分子机制和功能.
- 评估ST8SIA6-AS1作为肝癌诊断生物标志物的潜力.
- 探索ST8SIA6-AS1作为HCC管理的治疗点.
主要方法:
- 文献综述和对HCC中ST8SIA6-AS1现有研究的分析.
- 检查分子通路,包括竞争的内源RNA (ceRNA) 网络,涉及ST8SIA6-AS1.1.
- 对ST8SIA6-AS1表达水平与临床数据和患者预后的相关性分析.
主要成果:
- 与正常肝脏组织相比,ST8SIA6-AS1在HCC组织中持续过度表达.
- 升高的ST8SIA6-AS1水平与不良的患者预后和晚期疾病相显著相关.
- ST8SIA6-AS1通过作为ceRNA促进HCC细胞的增殖,迁移和入侵,从而促进肝癌发生.
结论:
- ST8SIA6-AS1是HCC中关键的致癌性lncRNA,通过其ceRNA活性促进瘤进展.
- ST8SIA6-AS1具有作为HCC诊断和预后敏感生物标志物的潜力.
- 向ST8SIA6-AS1可能为治疗肝癌提供一种新的治疗策略.
更多相关视频
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
6.4K
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
1.4K
相关概念视频
02:39lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
03:18Non-LTR Retrotransposons
11.4K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.4K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
02:53Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K